Snowball logo
logo
KG_logo

KING PHARMACEUTICALS INC

KG • NYSE
$5.12+$0.26  (5.35%)
Estimate
EPS
-12.22
Beta
1.045
Growth
Revenue, YoY
1,130.22%
Net income, YoY
-111.56%
FCF, YoY
-6,754.12%
About the company
Ticker
KG
ISIN
BMG5260K1027
Country
Bermuda
Sector (GICS)
Healthcare
Kestrel Group Ltd engages in the reinsurance business. It operates through two segments: Program Services and Legacy Reinsurance. The company offers fronting services to insurance program managers, managing general agencies, reinsurers, and reinsurance brokers in Bermuda. The company is based in Hamilton, Bermuda.

Frequently asked questions

What sector does KING PHARMACEUTICALS INC (KG) operate in?

KING PHARMACEUTICALS INC belongs to the Healthcare sector and operates in the Insurance - Reinsurance industry.

What is KING PHARMACEUTICALS INC (KG) current stock price?

As of the latest data, KING PHARMACEUTICALS INC stock price is $5.12, with a previous close of $4.86. KING PHARMACEUTICALS INC gained $0.26 in the last trading session, representing a 5.35% increase.

What is KING PHARMACEUTICALS INC (KG) current market capitalization?

KING PHARMACEUTICALS INC market cap is approximately 40.06 million.

What is KING PHARMACEUTICALS INC (KG) Earnings Per Share (EPS)?

The trailing EPS is -$12.22.

What is KING PHARMACEUTICALS INC (KG) EBITDA?

KING PHARMACEUTICALS INC EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -4.45 million.

Does KING PHARMACEUTICALS INC (KG) pay dividends?

No. KING PHARMACEUTICALS INC does not pay a dividend.

When is KING PHARMACEUTICALS INC (KG) next earnings report?

KING PHARMACEUTICALS INC is expected to release its next earnings report on September 30, 2026.

What is KING PHARMACEUTICALS INC (KG) beta (volatility) score?

KING PHARMACEUTICALS INC has a beta of 1.045, meaning its volatility is roughly in line with the market.